Probióticos, prebióticos y simbióticos en el tratamiento de la obesidad: una nueva visión
Fecha
2023
Título de la revista
ISSN de la revista
Título del volumen
Editor
Universidad Católica de Cuenca
Resumen
Descripción
Obesity is a chronic non-communicable disease whose prevalence has doubled during the last three decades, becoming, along with its metabolic complications, a worldwide public health problem. Recently, the alteration of the intestinal microbiota balance, known as dysbiosis, has been identified as a possible pathophysiological process that promotes weight gain in individuals who suffer from it. Dietary intervention with prebiotics, probiotics, or symbiotics aimed at correcting intestinal dysbiosis in obese patients can provide health benefits by facilitating weight loss and maintenance, improving constipation, glucose, and lipid levels, as well as immunity and expression of regulatory cytokines, thus contributing to the reduction of the chronic inflammatory process of intestinal cells.
Palabras clave
Obesity,, probiotics, symbiotics, overweight,, intestinal microbiota,, intestinal dysbiosis,, prebiotics
Citación
Vizueta Sánchez, A. S. ., Ortiz Benavides, R. E. ., & Jiménez Zeas, . F. P. . (2022). Probiotics, prebiotics, and symbiotics in the treatment of obesity: A new vision. Gaceta Médica De Caracas, 130(4). Recuperado a partir de http://saber.ucv.ve/ojs/index.php/rev_gmc/article/view/25330
